Sarepta’s gene therapy vector wins FDA platform technology status
Sarepta Therapeutics said Wednesday it won “platform technology” status for one of its gene therapy components, marking the first public disclosure from a company to receive the long-awaited FDA designation. ...
Sarepta Therapeutics said Wednesday it won “platform technology” status for one of its gene therapy components, marking the first public disclosure from a company to receive the long-awaited FDA designation. ...
